Gender matter! EUKON move on mission 5
Caserta, ITALY – August 8th, 2023 We are absolutely…
News
EUKON FT1000 ranking 2022 on Financial Times
FT 1000: the sixth annual list of Europe’s fastest-growing companies…
EUKON Leader della Crescita 2022
Leader della Crescita is rank of first 450 companies, done…
Next Generation PCI - Symposia at GISE 42, Milan 7th Oct 2021
EUKON and SMT present Next Generation PCI Symposia at GISE…
Expanding your frontiers in Structural Interventions - Symposia at GISE 42, Milan 7th Oct 2021
EUKON SMT present Innovations in Structural Heart Intervention PFO and TAVI…
FAVOR III China: QFR-Guided PCI Strategy vs. Angiography-Guided Strategy
FAVOR III China has bees published on Lancet and simultaneously…
15 minutes with... - Interview to dr. Stefano Galli
Dr Stefano Galli Interventional Cardiologist at “Cardiologico Monzino” in Milan…
It continues the interview series to experts on "The Vulnerable Patient"
In this interview Dr Simone Biscaglia, S. Anna University in…
EUKON and M.A.C. Healthcare Cybersecurity
Caserta, ITALY – September 8th, 2021 — EUKON’ experience in…
Multicenter clinical evaluation of a piezoresistive-MEMSsensor rapid-exchange pressure microcatheter system for fractional flow reserve measurement-2021
Multicenter-clinical-evaluation-of-a-piezoresistive-MEMSsensor-rapid-exchange-pressure-microcatheter-system-for-fractional-flow-reserve-measurement-2021.pdf This multicenter, prospective clinical study investigates whether the…
New interview on theme of VULNERABLE PATIENT.
Today dr Luigi di Serafino of University Federico II in…
15 minutes with... - Interview to prof. Paolo Calabrò
The VULNERABLE PATIENT WHO is the vulnerable patient ? HOW…
SAVE THE DATE - GISE TIP 2021 "Live in the box" on interventional phisiology June 18th at 14:30 CET
On June 18th at 14:30 CET Live In The Box…
SUPRAFLEX-TALENT trial 3yr follow-up has been presented at EuroPCR 2021
At EuroPCR 2021 TALENT 3yrs follow up has been presented.…
“CONTEMPORARY ADOPTION OF INVASIVE CORONARY PHYSIOLOGY WITH MICROCATHETER-BASED TECHNOLOGY”
Physiology-guided PCI in MVD Chairman Prof. Emanuele Barbato and Dr…
IVUS + NIRS: The PROSPECT II Study Published on The Lancet
11 March 2021 The PROSPECT II Study has been published…
Management of vulnerable plaque virtual webinar on March 5th, 2021 - SAVE the DATE
On March 5th at 8:00 am ET (14:00 CET) presented…
‘True North’ Precise PCI Training Courses FFR Online Summit Forum Feb 5th, 2021
February 5th（Fri.） 9:00-11:10 am (C.E.T.) Insight Lifetech Co., Ltd We…
APT Symposium CTO Feb 4th, 2021
CollecTiOn Sharing Expertise through West and East Chairperson: Prof. Jianping…
QFR - Functional assessment of one or more coronary lesions?
It’s time of QFR the most innovative, accurate, easy and…
NEWS at GISE CTO 2020
Claudia Mugnoz interviews Prof. Varbella and Dr. Cerrato “Evolution and…
True Physio Microcatheter for FFR in Italy soon!
After get approval from National Medical Products Admnistation and CE…
NIRS-IVUS for decision making in ACS
How can influence NIRS-IVUS of interventional cardiologists daily?
Anatomy and physiological assessment in one? With QFR you can do it !
Watch video to discover how.
Strategic roadmap of the Italian Society of Interventional Cardiology (SICI-GISE): guaranteeing patients the appropriate therapies
Roadmap to guarantee homogeneous access throughout the whole national territory…
The Impact of Coronary Physiology on Clinical Decision Making by P. Serruys
Click here to see where do we stand?
IVUS + NIRS: The PROSPECT II Study
The PROSPECT II study was presented as Late-Breaking Clinical Trials…
IVUS + NIRS: The PROSPECT ABSORB Study
For read click on The PROSPECT ABSORB Study (Jacc 2020)